1 results
28/Apr/2025
DOI: 10.31744/einstein_journal/2025AO1124
Highlights ■ Evaluation of a corticosteroid-free antiemetic regimen. ■ Primary endpoint: 46% nausea control. ■ Secondary endpoint: 68% emesis control. ■ Comparable to standard four-drug protocols. ABSTRACT Objective: Chemotherapy-induced nausea and vomiting are highly prevalent adverse events that can lead to poor treatment adherence and a decreased quality of life. To the best of our knowledge, the complete omission of dexamethasone from any regimen for preventing nausea and vomiting has not yet been evaluated. This study aimed to evaluate the […]
Keywords: Antineoplastic agents; Breast neoplasms; Dexamethasone; Drug therapy; Drug-related side effects and adverse reactions; Nausea; Olanzapine; Vomiting